Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:22 pm Purchase | 2024-09-30 | 13G | Aptose Biosciences Inc. APTO | Armistice Capital, LLC | 1,955,202 9.990% | 1,955,202 (New Position) | Filing History |
| 2024-04-26 12:54 pm Unchanged | 2024-04-24 | 13D | Aptose Biosciences Inc. APTO | Hanmi Pharmaceutical Co. Ltd. | 2,989,415 19.020% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:51 pm Sale | 2023-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 120,132 1.500% | -5,932,735 (-98.02%) | Filing History |
| 2024-02-02 6:05 pm Purchase | 2024-01-31 | 13D | Aptose Biosciences Inc. APTO | Hanmi Pharmaceutical Co. Ltd. | 2,989,415 22.170% | 2,105,263 (+238.11%) | Filing History |
| 2023-09-11 6:23 pm Purchase | 2023-09-06 | 13D | Aptose Biosciences Inc. APTO | Hanmi Pharmaceutical Co. Ltd. | 884,152 12.070% | 884,152 (New Position) | Filing History |
| 2023-02-14 4:56 pm Sale | 2022-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 403,524 6.600% | -103,455 (-20.41%) | Filing History |
| 2023-01-17 06:05 am Purchase | 2022-05-04 | 13G | Aptose Biosciences Inc. APTO | Fletcher Aaron G.L. | 416,453 6.770% | 416,453 (New Position) | Filing History |
| 2022-02-14 08:03 am Purchase | 2021-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 506,980 8.500% | 22,135 (+4.57%) | Filing History |
| 2022-02-11 4:15 pm Sale | 2021-12-31 | 13G | Aptose Biosciences Inc. APTO | ORBIMED CAPITAL LLC | 0 0.000% | -535,333 (Position Closed) | Filing History |
| 2021-08-09 8:00 pm Purchase | 2021-08-03 | 13G | Aptose Biosciences Inc. APTO | Wilson Donald R. Jr. | 592,829 9.997% | 61,084 (+11.49%) | Filing History |
| 2021-02-17 3:05 pm Sale | 2020-12-31 | 13G | Aptose Biosciences Inc. APTO | Consonance Capital Management LP | 0 0.000% | -403,900 (Position Closed) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Aptose Biosciences Inc. APTO | Consonance Capital Management LP | 403,900 11.000% | 403,900 (New Position) | Filing History |
| 2021-02-16 2:37 pm Sale | 2020-12-31 | 13G | Aptose Biosciences Inc. APTO | Consonance Capital Management LP | 0 0.000% | -318,146 (Position Closed) | Filing History |
| 2021-02-12 4:42 pm Purchase | 2020-12-31 | 13G | Aptose Biosciences Inc. APTO | ORBIMED CAPITAL LLC | 535,333 9.040% | 535,333 (New Position) | Filing History |
| 2021-02-12 3:25 pm Purchase | 2020-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 484,845 8.200% | 81,256 (+20.13%) | Filing History |
| 2021-02-01 4:31 pm Purchase | 2020-12-21 | 13G | Aptose Biosciences Inc. APTO | Wilson Donald R. Jr. | 531,745 8.980% | 366,869 (+222.51%) | Filing History |
| 2021-01-15 10:54 am Sale | 2021-01-15 | 13G | Aptose Biosciences Inc. APTO | Abramson Herbert | 245,800 4.100% | -28,200 (-10.29%) | Filing History |
| 2020-02-14 12:34 pm Purchase | 2019-12-31 | 13G | Aptose Biosciences Inc. APTO | Consonance Capital Management LP | 318,146 6.270% | 318,146 (New Position) | Filing History |
| 2020-02-14 12:18 pm Purchase | 2019-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 403,589 8.000% | 403,589 (New Position) | Filing History |